Related Experiment Videos
Barrett's esophagus: clinical characteristics
James C Reynolds1, Poneh Rahimi, David Hirschl
1Division of Gastroenterology and Hepatology, MCP Hahnemann University, 219 North Broad Street, Philadelphia, PA 19107, USA. jr44@exchange1.drexel.edu
Gastroenterology Clinics of North America
|July 24, 2002
Summary
Barrett's adenocarcinoma, a cancer linked to acid reflux, is rising. Early detection through surveillance is key, as advanced stages have poor survival rates.
Area of Science:
- Gastroenterology
- Oncology
- Epidemiology
Background:
- Barrett's metaplasia affects 6-14% of individuals with gastroesophageal reflux.
- Barrett's adenocarcinomas are increasing, with 0.5-1% of Barrett's patients developing cancer.
- Risk factors include heartburn frequency/duration, male gender, and Caucasian race; obesity and smoking are weak factors.
Purpose of the Study:
- To review the current understanding of Barrett's adenocarcinoma.
- To highlight the importance of surveillance for early detection and improved outcomes.
Main Methods:
- Literature review and synthesis of epidemiological data.
- Analysis of risk factors and survival determinants for Barrett's adenocarcinoma.
Main Results:
- Survival is critically dependent on tumor invasion depth (stage).
- Metastasis is common once the muscularis propria is invaded, often undetected by initial staging.
- Current therapies offer limited survival benefits for metastatic disease.
Conclusions:
- Effective surveillance strategies are crucial for reducing morbidity and mortality.
- Early detection via surveillance is the only current method to improve survival for Barrett's adenocarcinoma.